Dr. Kristin Hsieh Joins the New York Proton Center
New York, NY – July 14, 2025 — The New York Proton Center (NYPC) announced that Dr. Kristin Hsieh has joined the organization as its newest physician. Dr. Hsieh will serve as lead physician for breast and gynecologic cancers.
Dr. Hsieh joins NYPC following a residency in radiation oncology at the Icahn School of Medicine at Mount Sinai, where she served as chief resident and was selected as an ASTRO (American Society for Radiation Oncology)-AstraZeneca radiation oncology training fellow. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons.
“I am honored to join the team at the New York Proton Center where I can combine advanced proton therapy with compassionate patient-centered care to help achieve the best possible outcomes,” said Dr. Hsieh. “It is a privilege to support patients and their loved ones during such a critical time in their lives and to be part of a center that is at the forefront of innovative cancer treatment.”
“We are thrilled to welcome Dr. Hsieh to the New York Proton Center,” said Dr. Charles B. Simone II, FASTRO, FACRO, Chief Medical Officer. “Her clinical and research expertise in breast and gynecologic cancers will further strengthen our ability to deliver world-class, compassionate care. Dr. Hsieh will be an invaluable asset to our patients and our team as we continue advancing the role of proton therapy in cancer treatment.”
Dr. Hsieh has authored research and publications on radiotherapy for breast, gynecologic, lung, and head and neck cancers, with additional research dedicated to addressing healthcare disparities and advancing mentorship in radiation oncology. She is a recipient of the prestigious Roentgen Resident/Fellow Research Award from the Radiological Society of North America and the Emerging Advocacy Grassroots Leadership Award from ASTRO. Dr. Hsieh is fluent in English and Mandarin Chinese.
About the New York Proton Center
The New York Proton Center (NYPC) is creating the gold standard for proton therapy, giving new hope to patients living with cancer. The NYPC is advancing new and better ways to fight cancer with proton therapy, a highly targeted form of radiation therapy with fewer treatment-related complications. In partnership with leading academic medical centers: Memorial Sloan Kettering Cancer Center, Montefiore Health System, and Mount Sinai Health System, NYPC is the only proton center in New York, attracting patients from around the country and the world. Through impactful clinical trials and game-changing clinical research, NYPC’s internationally renowned clinical team continues to revolutionize cancer treatment while offering patients individualized, highly skilled and compassionate care.